Sacral Tumors and Management

Orthopedic Clinics of North America

Volumn 40, Issue 1, 2009, Pages 105-123

  Varga, Peter Paul ^a   Bors, Istvan ^a   Lazary, Aron ^a,b  

^a National Center for Spinal Disorders   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Outcome; Sacrum; Stabilization; Surgery; Tumor

Indexed keywords

CETUXIMAB; CISPLATIN; GADOLINIUM; GEFITINIB; GELFOAM; IMATINIB; POLYVINYL ALCOHOL; RAZOXANE;

ANEURYSMAL BONE CYST; ARTIFICIAL EMBOLISM; BONE BIOPSY; BONE REMODELING; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHONDROSARCOMA; CHORDOMA; CLINICAL FEATURE; COIL EMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; EWING SARCOMA; FIBROSARCOMA; HEMANGIOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOW DRUG DOSE; MYELOMA; NEURILEMOMA; NEUROFIBROMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOBLASTOMA; OSTEOCLASTOMA; OSTEOID OSTEOMA; OSTEOSARCOMA; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REHABILITATION CARE; REVIEW; SACRAL SPINAL CORD; SACRUM; SPINAL CORD DECOMPRESSION; SPINE METASTASIS; SPINE STABILIZATION; SPINE TUMOR; STEREOTACTIC RADIOSURGERY; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

HUMANS; ORTHOPEDIC PROCEDURES; SACRUM; SPINAL NEOPLASMS;

EID: 57149136401     PISSN: 00305898     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ocl.2008.09.010     Document Type: Review

References (84)

1. Feldenzer J.A., McGauley J.L., and McGillicuddy J.E. Sacral and presacral tumors: problems in diagnosis and management. Neurosurgery 25 6 (1989) 884-891
2. Disler D.G., and Miklic D. Imaging findings in tumors of the sacrum. AJR Am J Roentgenol 173 6 (1999) 1699-1706
3. McMaster M.L., Goldstein A.M., Bromley C.M., et al. Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control 12 1 (2001) 1-11
4. Pritchard D.J., Lunke R.J., Taylor W.F., et al. Chondrosarcoma: a clinicopathologic and statistical analysis. Cancer 45 1 (1980) 149-157
5. York J.E., Berk R.H., Fuller G.N., et al. Chondrosarcoma of the spine: 1954 to 1997. J Neurosurg 90 1 Suppl (1999) 73-78
6. Bergh P., Gunterberg B., Meis-Kindblom J.M., et al. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases. Cancer 91 7 (2001) 1201-1212
7. Murphey M.D., Andrews C.L., Flemming D.J., et al. From the archives of the AFIP. Primary tumors of the spine: radiologic pathologic correlation. Radiographics 16 5 (1996) 1131-1158
8. Vrionis F.D., and Small J. Surgical management of metastatic spinal neoplasms. Neurosurg Focus 15 5 (2003) 1-8
9. Bagley C.A., and Gokaslan Z.L. Cauda equina syndrome caused by primary and metastatic neoplasms. Neurosurg Focus 16 6 (2004) 11-18
10. Manaster B.J., and Graham T. Imaging of sacral tumors. Neurosurg Focus 15 2 (2003) 1-8
11. Byun W.M., Jang H.W., Kim S.W., et al. Diffusion-weighted magnetic resonance imaging of sacral insufficiency fractures: comparison with metastases of the sacrum. Spine 32 26 (2007) E820-E824
12. Zhang H., Yoshikawa K., Tamura K., et al. Carbon-11-methionine positron emission tomography imaging of chordoma. Skeletal Radiol 33 9 (2004) 524-530
13. Ozerdemoglu R.A., Thompson Jr. R.C., Transfeldt E.E., et al. Diagnostic value of open and needle biopsies in tumors of the sacrum. Spine 28 9 (2003) 909-915
14. Heyer C.M., Al-Hadari A., Mueller K.M., et al. Effectiveness of CT-Guided percutaneous biopsies of the spine an analysis of 202 examinations. Acad Radiol 15 7 (2008) 901-911
15. Varga P.P., Hoffer Z., and Bors I. Computer-assisted percutaneous transiliac approach to tumorous malformation of the sacrum. Comput Aided Surg 6 4 (2001) 212-216
16. Bergh P., Kindblom L.G., Gunterberg B., et al. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer 88 9 (2000) 2122-2134
17. Lee F.Y., Mankin H.J., Fondren G., et al. Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am 81 3 (1999) 326-338
18. Butler M.G., Dahir G.A., Hedges L.K., et al. Cytogenetic, telomere, and telomerase studies in five surgically managed lumbosacral chordomas. Cancer Genet Cytogenet 85 1 (1995) 51-57
19. Klingler L., Shooks J., Fiedler P.N., et al. Microsatellite instability in sacral chordoma. J Surg Oncol 73 2 (2000) 100-103
20. Klingler L., Trammell R., Allan D.G., et al. Clonality studies in sacral chordoma. Cancer Genet Cytogenet 171 1 (2006) 68-71
21. Nasir N., Aquilina K., Ryder D.Q., et al. Garre's chronic diffuse sclerosing osteomyelitis of the sacrum: a rare condition mimicking malignancy. Br J Neurosurg 20 6 (2006) 415-419
22. Kumar A., Varshney M.K., and Trikha V. Unusual presentation of isolated sacral tuberculosis. Joint Bone Spine 73 6 (2006) 751-752
23. Destombe C., Botton E., Le Gal G., et al. Investigations for bone metastasis from an unknown primary. Joint Bone Spine 74 1 (2007) 85-89
24. Maranzano E., Trippa F., Chirico L., et al. Management of metastatic spinal cord compression. Tumori 89 5 (2003) 469-475
25. Loblaw D.A., and Laperriere N.J. Emergency treatment of malignant extradural spinal cord compression: an evidence-based guideline. J Clin Oncol 16 4 (1998) 1613-1624
26. Masala S., Konda D., Massari F., et al. Sacroplasty and iliac osteoplasty under combined CT and fluoroscopic guidance. Spine 31 18 (2006) E667-E669
27. Fujibayashi S., Neo M., and Nakamura T. Palliative dual iliac screw fixation for lumbosacral metastasis. Technical note. J Neurosurg Spine 7 1 (2007) 99-102
28. Patchell R.A., Tibbs P.A., Regine W.F., et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366 9486 (2005) 643-648
29. Feigenberg S.J., Marcus Jr. R.B., Zlotecki R.A., et al. Radiation therapy for giant cell tumors of bone. Clin Orthop Relat Res 411 (2003) 207-216
30. York J.E., Kaczaraj A., Abi-Said D., et al. Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery 44 1 (1999) 74-79 [discussion: 9-0]
31. Raque Jr. G.H., Vitaz T.W., and Shields C.B. Treatment of neoplastic diseases of the sacrum. J Surg Oncol 76 4 (2001) 301-307
32. Schwartz L.H., Okunieff P.G., Rosenberg A., et al. Radiation therapy in the treatment of difficult giant cell tumors. Int J Radiat Oncol Biol Phys 17 5 (1989) 1085-1088
33. Imai R., Kamada T., Tsuji H., et al. Carbon ion radiotherapy for unresectable sacral chordomas. Clin Cancer Res 10 17 (2004) 5741-5746
34. Park L., Delaney T.F., Liebsch N.J., et al. Sacral chordomas: impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys 65 5 (2006) 1514-1521
35. Nakajo M., Ohkubo K., Fukukura Y., et al. Treatment of recurrent chordomas by percutaneous ethanol injection therapy and radiation therapy. Acta Radiol 47 3 (2006) 297-300
36. Gibbs I.C., Kamnerdsupaphon P., Ryu M.R., et al. Image-guided robotic radiosurgery for spinal metastases. Radiother Oncol 82 2 (2007) 185-190
37. Gibbs I.C. Spinal and paraspinal lesions: the role of stereotactic body radiotherapy. Front Radiat Ther Oncol 40 (2007) 407-414
38. Rhomberg W., Bohler F.K., Novak H., et al. A small prospective study of chordomas treated with radiotherapy and razoxane. Strahlenther Onkol 179 4 (2003) 249-253
39. DeLaney T.F., Park L., Goldberg S.I., et al. Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys 61 2 (2005) 492-498
40. Skubitz K.M., and D'Adamo D.R. Sarcoma. Mayo Clin Proc 82 11 (2007) 1409-1432
41. Paulussen M., Ahrens S., Craft A.W., et al. Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients. J Clin Oncol 16 9 (1998) 3044-3052
42. Kaban L.B., Troulis M.J., Ebb D., et al. Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. J Oral Maxillofac Surg 60 10 (2002) 1103-1111 [discussion: 11-3]
43. Dominkus M., Ruggieri P., Bertoni F., et al. Histologically verified lung metastases in benign giant cell tumours-14 cases from a single institution. Int Orthop 30 6 (2006) 499-504
44. Fleming G.F., Heimann P.S., Stephens J.K., et al. Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases. Cancer 72 3 (1993) 714-718
45. Schonegger K., Gelpi E., Prayer D., et al. Recurrent and metastatic clivus chordoma: systemic palliative therapy retards disease progression. Anticancer Drugs 16 10 (2005) 1139-1143
46. Casali P.G., Messina A., Stacchiotti S., et al. Imatinib mesylate in chordoma. Cancer 101 9 (2004) 2086-2097
47. Casali P.G., Stacchiotti S., and Grosso F. Adding cisplatin (CDDP) to imantinib (IM) re-establishes tumor response following secondary resistance to IM in advanced chordoma [abstract]. J Clin Oncol 25 Suppl 18 (2007) 10038
48. Stacchioni S., Ferrari S., and Ferraresi V. Imatinib mesylate in advanced chordoma: a multicenter phase II study [abstract]. J Clin Oncol 25 Suppl 18 (2007) 10003
49. Hof H., Welzel T., and Debus J. Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma. Onkologie 29 12 (2006) 572-574
50. Link M.P., Goorin A.M., Miser A.W., et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314 25 (1986) 1600-1606
51. Bacci G., Longhi A., Cesari M., et al. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients. Cancer 106 12 (2006) 2701-2706
52. Chou A.J., Merola P.R., Wexler L.H., et al. Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience. Cancer 104 10 (2005) 2214-2221
53. Grier H.E., Krailo M.D., Tarbell N.J., et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348 8 (2003) 694-701
54. Ferrari S., Mercuri M., Rosito P., et al. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity. J Chemother 10 6 (1998) 484-491
55. Hoffmann C., Ahrens S., Dunst J., et al. Pelvic Ewing sarcoma: a retrospective analysis of 241 cases. Cancer 85 4 (1999) 869-877
56. Hosalkar H.S., Jones K.J., King J.J., et al. Serial arterial embolization for large sacral giant-cell tumors: mid- to long-term results. Spine 32 10 (2007) 1107-1115
57. Konya A., and Szendroi M. Aneurysmal bone cysts treated by superselective embolization. Skeletal Radiol 21 3 (1992) 167-172
58. Gottfried O.N., Schmidt M.H., and Stevens E.A. Embolization of sacral tumors. Neurosurg Focus 15 2 (2003) E4
59. Chiras J., Adem C., Vallee J.N., et al. Selective intra-arterial chemoembolization of pelvic and spine bone metastases. Eur Radiol 14 10 (2004) 1774-1780
60. Gunterberg B., Romanus B., and Stener B. Pelvic strength after major amputation of the sacrum. An experimental study. Acta Orthop Scand 47 6 (1976) 635-642
61. Fourney D.R., Rhines L.D., Hentschel S.J., et al. En bloc resection of primary sacral tumors: classification of surgical approaches and outcome. J Neurosurg Spine 3 2 (2005) 111-122
62. Hulen C.A., Temple H.T., Fox W.P., et al. Oncologic and functional outcome following sacrectomy for sacral chordoma. J Bone Joint Surg [Am] 88 7 (2006) 1532-1539
63. Sar C., and Eralp L. Surgical treatment of primary tumors of the sacrum. Arch Orthop Trauma Surg 122 3 (2002) 148-155
64. Zhang H.Y., Thongtrangan I., Balabhadra R.S., et al. Surgical techniques for total sacrectomy and spinopelvic reconstruction. Neurosurg Focus 15 2 (2003) 1-10
65. Zileli M., Hoscoskun C., Brastianos P., et al. Surgical treatment of primary sacral tumors: complications associated with sacrectomy. Neurosurg Focus 15 5 (2003) 1-8
66. Stener B., and Gunterberg B. High amputation of the sacrum for extirpation of tumors. Principles and technique. Spine 3 4 (1978) 351-366
67. Localio S.A., Eng K., and Ranson J.H. Abdominosacral approach for retrorectal tumors. Ann Surg 191 5 (1980) 555-560
68. Furukawa H., Yamamoto Y., Igawa H.H., et al. Gluteus maximus adipomuscular turnover or sliding flap in the surgical treatment of extensive sacral chordomas. Plast Reconstr Surg 105 3 (2000) 1013-1016
69. Abhinav K., Shaaban M., Raymond T., et al. Primary reconstruction of pelvic floor defects following sacrectomy using Permacoltrade mark graft. Eur J Surg Oncol (2008) [epub ahead of print]
70. Hugate Jr. R.R., Dickey I.D., Phimolsarnti R., et al. Mechanical effects of partial sacrectomy: when is reconstruction necessary?. Clin Orthop Relat Res 450 (2006) 82-88
71. Allen Jr. B.L., and Ferguson R.L. The Galveston technique for L rod instrumentation of the scoliotic spine. Spine 7 3 (1982) 276-284
72. Gokaslan Z.L., Romsdahl M.M., Kroll S.S., et al. Total sacrectomy and Galveston L-rod reconstruction for malignant neoplasms. Technical note. J Neurosurg 87 5 (1997) 781-787
73. Tomita K., and Tsuchiya H. Total sacrectomy and reconstruction for huge sacral tumors. Spine 15 11 (1990) 1223-1227
74. Jackson R.J., and Gokaslan Z.L. Spinal-pelvic fixation in patients with lumbosacral neoplasms. J Neurosurg 92 1 Suppl (2000) 61-70
75. Murakami H., Kawahara N., Tomita K., et al. Biomechanical evaluation of reconstructed lumbosacral spine after total sacrectomy. J Orthop Sci 7 6 (2002) 658-664
76. Guo Y., Palmer J.L., Shen L., et al. Bowel and bladder continence, wound healing, and functional outcomes in patients who underwent sacrectomy. J Neurosurg Spine 3 2 (2005) 106-110
77. Bauer K.A., and Ghazinouri R. Rehabilitation after total sacrectomy. Rehabilitation Oncology (2005). http://findarticles.com/p/articles/mi_qa3946/is_200501/ai_n15348089 Avail-able at:
78. Todd Jr. L.T., Yaszemski M.J., Currier B.L., et al. Bowel and bladder function after major sacral resection. Clin Orthop Relat Res 397 (2002) 36-39
79. McPherson C.M., Suki D., McCutcheon I.E., et al. Metastatic disease from spinal chordoma: a 10-year experience. J Neurosurg Spine 5 4 (2006) 277-280
80. Osaka S., Kodoh O., Sugita H., et al. Clinical significance of a wide excision policy for sacrococcygeal chordoma. J Cancer Res Clin Oncol 132 4 (2006) 213-218
81. Ishii K., Chiba K., Watanabe M., et al. Local recurrence after S2-3 sacrectomy in sacral chordoma. Report of four cases. J Neurosurg 97 1 Suppl (2002) 98-101
82. Jeanrot C., Vinh T.S., Anract P., et al. [Sacral chordoma: retrospective review of 11 surgically treated cases]. Rev Chir Orthop Reparatrice Appar Mot 86 7 (2000) 684-693
83. Bertoni F., Bacchini P., and Staals E.L. Malignancy in giant cell tumor of bone. Cancer 97 10 (2003) 2520-2529
84. Boriani S., and Weinstein J.N. Oncologic classification of vertebral neoplasms. In: Dickman C.A., Fehlings M.G., and Gokaslan Z.L. (Eds). Spinal cord and spinal column tumors (2006), Thieme Medical Publishers, Inc., New York 37